POLYCLONAL ANTIBODY MARKET ANALYSIS

Polyclonal Antibody Market, By Type (Primary Antibody, Secondary Antibody), By Source (Rabbits, Goats, Sheep, Others), By Application (Academic Research, Diagnostics, Others), By End User (Academic & Research Institutes, Pharmaceutical and Biotechnology Companies, Others), , By Region (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa)

Published In : Dec 2023
Code : CMI4347
Pages :190
Formats :
Excel and PDF
Industry : Clinical Diagnostic

Polyclonal Antibody MarketSize and Trends

The global polyclonal antibody market size is expected to reach US$ 1,638.7 Mn by 2030, from US$ 1,096.9 Mn in 2023, exhibiting compound annual growth rate (CAGR) of 5.9% during the forecast period. The global polyclonal antibody market has strong growth potential over the next five years.

Global Polyclonal Antibody Market Trends

Automation in polyclonal antibody production: The trend of increasing automation in polyclonal antibody production processes is having a significant impact on the global polyclonal antibody market. As biotechnology companies look to improve efficiency and reduce production costs, many are investing heavily in automated systems to handle repetitive tasks involved in polyclonal antibody development. Automated liquid handling machines, robotic arms, and advanced imaging systems are helping to standardize and scale up antibody production workflows. This allows individual companies to meet the large and growing demand for polyclonal antibodies from the research, diagnostics, and therapeutics sectors while minimizing the need for additional hiring and facility expansion.